Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.
Sector:
Health Technology
Industry:
Pharmaceuticals Generic
Employees:
17,400
Frequently Asked Questions
What is Market Cap of Allergan plc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Allergan plc market cap is $63.66B.
What is the 52-week high for Allergan plc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Allergan plc 52 week high is $202.22 as of October 03, 2025.
What is the 52-week low for Allergan plc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Allergan plc 52 week low is $114.27 as of October 03, 2025.
What was Allergan plc stock price yesterday?
Allergan plc stock price yesterday was $193.02.
What is the PE ratio of Allergan plc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Allergan plc’s P/E ratio is None.
What is the Price-to-Book ratio of Allergan plc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Allergan plc P/B ratio is 1.0973.
What is Allergan plc's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Allergan plc's EBITDA is 10.47.
What is the 50-day moving average of Allergan plc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Allergan plc 50-day moving average is $182.89.
